124 posts · 132,311 views
The latest news, views and opinions on cancer research and cancer biology - from Cancer Research UK, the UK's largest cancer charity
Cancer Research UK
124 posts
Sort by: Latest Post, Most Popular
View by: Condensed, Full
by Cancer Research UK in Cancer Research UK - Science Update
We’ve funded many of the world’s most successful trials of new treatment for children with cancer, and this has contributed to childhood cancer survival rates rising to an all-time high. But childhood brain tumours remain an area where progress has … Continue reading →... Read more »
Swartling FJ, Savov V, Persson AI, Chen J, Hackett CS, Northcott PA, Grimmer MR, Lau J, Chesler L, Perry A.... (2012) Distinct Neural Stem Cell Populations Give Rise to Disparate Brain Tumors in Response to N-MYC. Cancer cell, 21(5), 601-13. PMID: 22624711
by Cancer Research UK in Cancer Research UK - Science Update
The course of drug development never did run smooth. Drug development pipelines – like the X-Factor – are littered with thousands of ‘hopefuls’ who fail to make the cut. Very few drugs survive the arduous journey from bench to bedside, … Continue reading →... Read more »
Aleksandar Sekulic, M.D., Ph.D.,, Michael R. Migden, M.D.,, Anthony E. Oro, M.D., Ph.D.,, Luc Dirix, M.D., Ph.D.,, Karl D. Lewis, M.D.,, John D. Hainsworth, M.D.,, James A. Solomon, M.D., Ph.D.,, Simon Yoo, M.D.,, Sarah T. Arron, M.D., Ph.D.,, Philip A. Friedlander, M.D., Ph.D.,.... (2012) Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma. New England Journal of Medicine, 2171-2179. info:/10.1056/NEJMoa1113713
Jean Y. Tang, Julian M. Mackay-Wiggan, Michelle Aszterbaum, Robert L. Yauch, Joselyn Lindgren, Kris Chang, Carol Coppola, Anita M. Chanana, Jackleen Marji, David R. Bickers.... (2012) Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome. N Engl J Med, 2180-2188. info:/10.1056/NEJMoa1113538
by Cancer Research UK in Cancer Research UK - Science Update
While the UK enjoyed the rather wet Jubilee celebrations this weekend, thousands of cancer experts gathered in Chicago for the world’s largest annual cancer conference, ASCO. Cancer Research UK’s Nell Barrie was there to hear about the latest treatment advances. … Continue reading →... Read more »
Topalian SL, Hodi FS, Brahmer JR, Gettinger SN, Smith DC, McDermott DF, Powderly JD, Carvajal RD, Sosman JA, Atkins MB.... (2012) Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer. The New England journal of medicine. PMID: 22658127
by Cancer Research UK in Cancer Research UK - Science Update
Over recent months we’ve written about exciting new research looking at how the genetic makeup of an individual patient’s cancer shifts and evolves as the disease develops and spreads. At the moment the only way to monitor this is to … Continue reading →... Read more »
Forshew, T., Murtaza, M., Parkinson, C., Gale, D., Tsui, D., Kaper, F., Dawson, S., Piskorz, A., Jimenez-Linan, M., Bentley, D.... (2012) Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA. Science Translational Medicine, 4(136), 136-136. DOI: 10.1126/scitranslmed.3003726
by Cancer Research UK in Cancer Research UK - Science Update
Earlier this week, the news was full of stories about a ‘blood test’ that can apparently predict a woman’s risk of breast cancer, years before she develops the disease. This sounds exciting. Being able to work out someone’s risk of … Continue reading →... Read more »
Brennan, K., Garcia-Closas, M., Orr, N., Fletcher, O., Jones, M., Ashworth, A., Swerdlow, A., Thorne, H., , ., Riboli, E.... (2012) Intragenic ATM Methylation in Peripheral Blood DNA as a Biomarker of Breast Cancer Risk. Cancer Research, 72(9), 2304-2313. DOI: 10.1158/0008-5472.CAN-11-3157
by Cancer Research UK in Cancer Research UK - Science Update
Over recent decades we have made huge progress in survival for many types of cancer, including breast, bowel, testicular, and prostate cancer as well as childhood cancers. But some types of cancer – including pancreatic, lung, and oesophageal cancers, as … Continue reading →... Read more »
Pérez-Mancera, P., Rust, A., van der Weyden, L., Kristiansen, G., Li, A., Sarver, A., Silverstein, K., Grützmann, R., Aust, D., Rümmele, P.... (2012) The deubiquitinase USP9X suppresses pancreatic ductal adenocarcinoma. Nature. DOI: 10.1038/nature11114
by Cancer Research UK in Cancer Research UK - Science Update
The emotion and anxiety aroused by a single word – ‘cancer’ – spans ages, sexes, nations, races and classes. But as we understand more about the disease, the idea that cancer is a single, common enemy, is increasingly being challenged. … Continue reading →... Read more »
Curtis, C., Shah, S., Chin, S., Turashvili, G., Rueda, O., Dunning, M., Speed, D., Lynch, A., Samarajiwa, S., Yuan, Y.... (2012) The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. DOI: 10.1038/nature10983
by Cancer Research UK in Cancer Research UK - Science Update
We need oxygen to survive. Even the cells in the deepest, darkest parts of our body can’t live without it. But some cancer cells adapt to survive in very low oxygen levels, and these end up being some of the … Continue reading →... Read more »
Yang, J., Staples, O., Thomas, L., Briston, T., Robson, M., Poon, E., Simões, M., El-Emir, E., Buffa, F., Ahmed, A.... (2012) Human CHCHD4 mitochondrial proteins regulate cellular oxygen consumption rate and metabolism and provide a critical role in hypoxia signaling and tumor progression. Journal of Clinical Investigation, 122(2), 600-611. DOI: 10.1172/JCI58780
by Cancer Research UK in Cancer Research UK - Science Update
In part one, we told the story of Cancer Research UK’s involvement in the race to identify BRCA1 – the first known breast cancer gene. Although this was a very important discovery, it wasn’t the end of the story. Along … Continue reading →... Read more »
Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, & Averill D. (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (New York, N.Y.), 265(5181), 2088-90. PMID: 8091231
Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, & Micklem G. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature, 378(6559), 789-92. PMID: 8524414
by Cancer Research UK in Cancer Research UK - Science Update
In this two-part post in our High-Impact Science series we look at Cancer Research UK’s role in the discovery of two of the most famous “cancer genes” known to science – BRCA1 and BRCA2. Faults in these genes are responsible … Continue reading →... Read more »
Easton DF, Bishop DT, Ford D, & Crockford GP. (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. American journal of human genetics, 52(4), 678-701. PMID: 8460634
Smith SA, DiCioccio RA, Struewing JP, Easton DF, Gallion HH, Albertsen H, Mazoyer S, Johansson B, Steichen-Gersdorf E, & Stratton M. (1994) Localisation of the breast-ovarian cancer susceptibility gene (BRCA1) on 17q12-21 to an interval of . Genes, chromosomes , 10(1), 71-6. PMID: 7519878
Albertsen HM, Smith SA, Mazoyer S, Fujimoto E, Stevens J, Williams B, Rodriguez P, Cropp CS, Slijepcevic P, & Carlson M. (1994) A physical map and candidate genes in the BRCA1 region on chromosome 17q12-21. Nature genetics, 7(4), 472-9. PMID: 7951316
Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, & Ding W. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (New York, N.Y.), 266(5182), 66-71. PMID: 7545954
Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, & Miki Y. (1994) BRCA1 mutations in primary breast and ovarian carcinomas. Science (New York, N.Y.), 266(5182), 120-2. PMID: 7939630
by Cancer Research UK in Cancer Research UK - Science Update
Here are a few thoughts on this morning’s headlines about ecstasy and cancer. (In case you missed them, they’re based on research from Birmingham, published in the New Investigational Drugs journal, in which researchers report that they’ve ‘redesigned’ the molecular structure of ecstasy to make it more effective at killing lab-grown blood cancer cells). Many [...]... Read more »
Wasik AM, Gandy MN, McIldowie M, Holder MJ, Chamba A, Challa A, Lewis KD, Young SP, Scheel-Toellner D, Dyer MJ.... (2011) Enhancing the anti-lymphoma potential of 3,4-methylenedioxymethamphetamine ('ecstasy') through iterative chemical redesign: mechanisms and pathways to cell death. Investigational new drugs. PMID: 21850491
by Cancer Research UK in Cancer Research UK - Science Update
As well as the ingenuity, dedication and skill of their staff, modern hospitals can’t function properly without a reliable electricity supply. This is so critical that hospitals have a back-up generator to keep their life-saving systems working in an emergency.. In a similar way, our cells also have their own emergency back-up systems. Thanks to [...]... Read more »
Frezza, C., Zheng, L., Folger, O., Rajagopalan, K., MacKenzie, E., Jerby, L., Micaroni, M., Chaneton, B., Adam, J., Hedley, A.... (2011) Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature. DOI: 10.1038/nature10363
by Cancer Research UK in Cancer Research UK - Science Update
Our immune system is our very own internal ‘police force’. It’s made up of disease-battling cells and proteins that travel through our bloodstream, searching out potentially harmful infections like the flu. In the past couple decades, the immune system’s role in cancer has come into sharp focus, and a whole scientific field of cancer immunotherapy [...]... Read more »
Porter DL, Levine BL, Kalos M, Bagg A, & June CH. (2011) Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia. The New England journal of medicine. PMID: 21830940
Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, & June CH. (2011) T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Science translational medicine, 3(95). PMID: 21832238
by Cancer Research UK in Cancer Research UK - Science Update
Today, a new study has led to headlines claiming that adding caffeine to sunscreen could improve its effectiveness in preventing skin cancer. But don’t chuck away the sunscreen just yet, nor pour your coffee into it – this was an interesting study in mice, but it doesn’t prove that adding caffeine to sunscreen would have any effect [...]... Read more »
Kawasumi, M., Lemos, B., Bradner, J., Thibodeau, R., Kim, Y., Schmidt, M., Higgins, E., Koo, S., Angle-Zahn, A., Chen, A.... (2011) Protection from UV-induced skin carcinogenesis by genetic inhibition of the ataxia telangiectasia and Rad3-related (ATR) kinase. Proceedings of the National Academy of Sciences, 108(33), 13716-13721. DOI: 10.1073/pnas.1111378108
by Cancer Research UK in Cancer Research UK - Science Update
For many, the 1980s represent social unrest and wardrobe disasters. But amidst the strikes and the legwarmers, the 1980s gave us much to be thankful for. For cancer scientists, it was a Renaissance period – a decade during which cancer research came of age and (unlike many of us) got a proper haircut. Cancer Research [...]... Read more »
Downward J, Yarden Y, Mayes E, Scrace G, Totty N, Stockwell P, Ullrich A, Schlessinger J, & Waterfield MD. (1984) Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature, 307(5951), 521-7. PMID: 6320011
by Cancer Research UK in Cancer Research UK - Science Update
As anyone who has lost a loved one to a brain tumour knows, the disease can be devastating. So headlines claiming that cats may be responsible for brain tumours – based on limited and tentative evidence – are not only misleading but also deeply insensitive to patients and their families. Despite recent advances in treating brain [...]... Read more »
Thomas, F., Lafferty, K., Brodeur, J., Elguero, E., Gauthier-Clerc, M., & Misse, D. (2011) Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common. Biology Letters. DOI: 10.1098/rsbl.2011.0588
by Cancer Research UK in Cancer Research UK - Science Update
We’re living through a revolution in cancer research. New technology is making it possible to find the genetic changes at the heart of cancer faster than ever before, unlocking the knowledge we need to save lives. Now Cancer Research UK is taking another big step towards beating cancer by taking part in the most ambitious [...]... Read more »
Stratton, M., Campbell, P., & Futreal, P. (2009) The cancer genome. Nature, 458(7239), 719-724. DOI: 10.1038/nature07943
Stratton, M. (2011) Exploring the Genomes of Cancer Cells: Progress and Promise. Science, 331(6024), 1553-1558. DOI: 10.1126/science.1204040
Gambacorti-Passerini, C., Antolini, L., Mahon, F., Guilhot, F., Deininger, M., Fava, C., Nagler, A., Della Casa, C., Morra, E., Abruzzese, E.... (2011) Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib. JNCI Journal of the National Cancer Institute, 103(7), 553-561. DOI: 10.1093/jnci/djr060
by Cancer Research UK in Cancer Research UK - Science Update
Beating lung cancer is one of our greatest challenges. It’s the most common cancer in the world – a staggering 1.61 million new cases are diagnosed every year. In the UK, it is the second most common cancer, and each year more than 38,000 people are diagnosed with the disease. And improvements in survival rates [...]... Read more »
The National Lung Screening Trial Research Team. (2011) Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. New England Journal of Medicine, 2147483647. DOI: 10.1056/NEJMoa1102873
Mao, J., Roth, M., Fishbein, M., Aberle, D., Zhang, Z., Rao, J., Tashkin, D., Goodglick, L., Holmes, E., Cameron, R.... (2011) Lung Cancer Chemoprevention with Celecoxib in Former Smokers. Cancer Prevention Research, 4(7), 984-993. DOI: 10.1158/1940-6207.CAPR-11-0078
by Cancer Research UK in Cancer Research UK - Science Update
At Cancer Research UK, we’re often asked about alleged “miracle cures” for cancer, usually based on claims made on the internet. There’s an impressive list of these collected on the Quackwatch website (here and here), ranging from the slightly wacky to the downright dangerous. In virtually all cases, when researchers have rigorously tested these treatments, [...]... Read more »
Bashford EF. (1911) CANCER, CREDULITY, AND QUACKERY. British medical journal, 1(2630), 1221-30. PMID: 20765638
Imperial Cancer Research Fund. (1907) IMPERIAL CANCER RESEARCH FUND. British medical journal, 2(2427), 26-9. PMID: 20763346
Power D. (1904) Notes on an Ineffectual Treatment of Cancer: Being a Record of Three Cases Injected with Dr. Otto Schmidt's Serum. British medical journal, 1(2249), 299-302. PMID: 20761353
No authors listed. (1906) THE COMPOSITION OF SOME CANCER "REMEDIES.". British medical journal, 1(2369), 1238. PMID: 20762692
by Cancer Research UK in Cancer Research UK - Science Update
Breast cancer survival is one of the big success stories of recent years. Thanks to improvements in screening and treatment more than 70 per cent of women now survive for more than ten years, compared to around 40 per cent back in the 1970s. But while this is cause for celebration, the statistics hide the [...]... Read more »
Robinson J, MacArthur S, Ross-Innes CS, Tilley WD, Neal DE, Mills IG, & Carroll JS. (2011) Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1. EMBO Journal. info:/
Do you write about peer-reviewed research in your blog? Use ResearchBlogging.org to make it easy for your readers — and others from around the world — to find your serious posts about academic research.
If you don't have a blog, you can still use our site to learn about fascinating developments in cutting-edge research from around the world.